Literature DB >> 920814

Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine.

H Ito, F L Coe.   

Abstract

Urine contains nondialyzable inhibitors of calcium oxalate crystal growth. We have pursued the hypothesis that these inhibitors may, in part, be acidic peptides and polyribonucleotide fragments. Homopolyribonucleotides and RNA inhibit calcium oxalate crystal growth at 5 x 10(-6) M of constituent ribonucleotide, whereas the monomer nucleotides are inactive at 10(-4) M. Poly-L-aspartic or glutamic acid are also inhibitory at 5 X 10(-6) M of amino acid, whereas the monomeric amino acids are inert. Gastric pepsin, a naturally occurring acidic peptide, is inhibitory. Incubation with nonspecific protease reduced the inhibitory effectiveness of normal human urine consistently and significantly, a fact compatible with an important contribution of peptides. A variable additional reduction was produced by subsequent treatment with ribonuclease, suggesting only a small role for polyribonucleotide. Sequential ion exchange and gel filtration chromatography and preparative disc gel electrophoresis yielded inhibitory material enriched with peptides that were strongly acidic and high in proline. Peptides and ribonucleotides seem to contribute to urinary nondialyzable crystal growth inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920814     DOI: 10.1152/ajprenal.1977.233.5.F455

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  The many roles of oxalate in nature.

Authors:  Lynwood H Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

2.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

3.  An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.

Authors:  S Sørensen; K Hansen; S Bak; S J Justesen
Journal:  Urol Res       Date:  1990

4.  Reflections on stones.

Authors:  F L Coe
Journal:  West J Med       Date:  1983-04

5.  Hydration feature of urinary compounds. Evidence for molecular abnormality in calcium oxalate urolithiasis.

Authors:  R Azoury; J Ramon; S Abrashkin; J Shalev; B Goldwasser
Journal:  Urol Res       Date:  1990

6.  The effect of serum on the crystallization of calcium oxalate in whole human urine: inhibition disguised as apparent promotion.

Authors:  K A Edyvane; R L Ryall; R D Mazzachi; V R Marshall
Journal:  Urol Res       Date:  1987

7.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Authors:  Y Nakagawa; V Abram; J H Parks; H S Lau; J K Kawooya; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

8.  Evaluation of the relative inhibitory potential of fractionated urinary macromolecules.

Authors:  R Azoury; B Goldwasser; Y Wax; S Perlberg; N Garti; S Sarig
Journal:  Urol Res       Date:  1985

9.  Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile.

Authors:  R T Holzbach; A Kibe; E Thiel; J H Howell; M Marsh; R E Hermann
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

10.  Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.

Authors:  S Sørensen; S J Justesen; A H Johnsen
Journal:  Urol Res       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.